These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 36097232

  • 1. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.
    Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM.
    Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
    [Abstract] [Full Text] [Related]

  • 2. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.
    Yang Y, Ji S, Liu S.
    Bioconjug Chem; 2014 Sep 17; 25(9):1720-9. PubMed ID: 25144854
    [Abstract] [Full Text] [Related]

  • 5. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr 17; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 6. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, Liu Z, Wang F, Chen X, Liu S.
    Mol Pharm; 2009 Apr 17; 6(1):231-45. PubMed ID: 19067525
    [Abstract] [Full Text] [Related]

  • 7. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C, Zhao H, Yang S, Shi J, Huang J, Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F.
    Mol Pharm; 2013 Aug 05; 10(8):2925-33. PubMed ID: 23768172
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
    Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ.
    J Biomed Sci; 2018 Feb 19; 25(1):17. PubMed ID: 29455647
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, radiolabeling and evaluation of [99mTc][Tc-HYNIC/EDDA]-Met(O) as a early agent for amino acid metabolic imaging in C6 glioblastoma tumor.
    Dinmohammadi F, Erfani M, Shamsaei M, Shirmardi SP, Goudarzi M.
    Bioorg Chem; 2023 Jan 19; 130():106237. PubMed ID: 36402025
    [Abstract] [Full Text] [Related]

  • 10. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
    Yang J, Guo H, Miao Y.
    Nucl Med Biol; 2010 Nov 19; 37(8):873-83. PubMed ID: 21055617
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.
    Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowiński P, Chauhan S, Pennington M, Liu S.
    Mol Pharm; 2013 Sep 03; 10(9):3304-14. PubMed ID: 23875883
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
    Zhou Y, Kim YS, Lu X, Liu S.
    Bioconjug Chem; 2012 Mar 21; 23(3):586-95. PubMed ID: 22369387
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, Zhu X, Xi L.
    Nucl Med Biol; 2015 Mar 21; 42(3):256-62. PubMed ID: 25516099
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-D(RGD): molecular imaging probe for diagnosis of αvβ3-positive tumors.
    Ramezanizadeh M, Masterifarahani A, Sadeghzadeh N, Abediankenari S, Mardanshahi A, Maleki F.
    Nucl Med Commun; 2020 Feb 21; 41(2):104-109. PubMed ID: 31834256
    [Abstract] [Full Text] [Related]

  • 18. Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer.
    Shaghaghi Z, Abedi SM, Hosseinimehr SJ.
    Biomed Pharmacother; 2018 Aug 21; 104():325-331. PubMed ID: 29775901
    [Abstract] [Full Text] [Related]

  • 19. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
    Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB.
    Nucl Med Biol; 2013 Aug 21; 40(6):788-94. PubMed ID: 23701702
    [Abstract] [Full Text] [Related]

  • 20. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.
    Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ.
    Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.